Article thumbnail

No Association of Functional Polymorphisms in Methlylenetetrahydrofolate Reductase and the Risk and Minor Physical Anomalies of Schizophrenia in Korean Population

By Su-Gyeong Kim, Joo Yun Song, Eun-Jeong Joo, Seong Hoon Jeong, Se Hyun Kim, Kyu Young Lee, Nam Young Lee, Yong Min Ahn, Yong Sik Kim and Myoung-Sun Roh


Methylenetetrahydrofolate reductase (MTHFR), a critical enzyme in folate metabolism, plays an important role in DNA methylation. It has been suggested that abnormal DNA methylation contributes to the pathogenesis of schizophrenia and congenital anomalies. The previous findings regarding the genetic relationship between MTHFR and schizophrenia are controversial. This study investigated the association of the two functional polymorphisms of MTHFR, C677T and A1298C, with the risk for schizophrenia. Furthermore, we conducted an updated meta-analysis on the two polymorphisms. In addition, we investigated the relationship between the polymorphisms and minor physical anomaly (MPA), which may represent neurodevelopmental aberrations in 201 schizophrenia patients and 350 normal control subjects. There was no significant association between either of the two polymorphisms and the risk of schizophrenia (chi-square = 0.001, df = 1, P = 0.971 for C677T; chi-square = 1.319, df = 1, P = 0.251 for A1298C). However, in meta-analysis, the C677T polymorphism showed a significant association in the combined and Asian populations (OR = 1.13, P = 0.005; OR = 1.21, P = 0.011, respectively) but not in the Korean and Caucasian populations alone. Neither polymorphism was associated with MPAs measured by the Waldrop scale (chi-square = 2.513, df = 2, P = 0.285). In conclusion, the present findings suggest that in the Korean population, the MTHFR polymorphisms are unlikely to be associated with the risk for schizophrenia and neurodevelopmental abnormalities related to schizophrenia

Topics: Original Article
Publisher: The Korean Academy of Medical Sciences
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2009). 118 SNPs of folate-related genes and risks of spina bifida and conotruncal heart defects.
  2. (2000). 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review.
  3. (1995). A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase.
  4. (1998). A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?
  5. (2000). Association between the methylenetetrahydrofolate reductase 677C-->T missense mutation and schizophrenia. Mol Psychiatry
  6. (2006). Association of 677C>T polymorphism of methylenetetrahydrofolate reductase (MTHFR) gene with bipolar disorder and schizophrenia. Neurosci Lett
  7. (2009). Association of plasma homocysteine and methylenetetrahydrofolate reductase C677T gene variant with schizophrenia: a Chinese Han population-based case-control study. Psychiatry Res
  8. (2005). Association of the C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene with schizophrenia: association is significant in men but not in women. Prog Neuropsychopharmacol Biol Psychiatry
  9. (2008). Bloodomics Consortium. Identification of variation in the platelet transcriptome associated with glycoprotein 6 haplotype. Platelets
  10. (2006). C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: a meta-analysis of genetic association studies. Psychiatr Genet
  11. (1998). C677T polymorphism in methylenetetrahydrofolate reductase gene and psychoses. Mol Psychiatry
  12. (2003). Development and application of DIGS-K (Diagnostic Interview for Genetic Studies-Korean). Schizophr Clin
  13. (2007). Distribution of 1298A>C polymorphism of methylenetetrahydrofolate reductase gene in patients with bipolar disorder and schizophrenia. Eur Psychiatry
  14. (2011). Effects of season of birth and a common MTHFR gene variant on the risk of schizophrenia. Eur Neuropsychopharmacol
  15. (2008). Epigenomic profiling reveals DNA-methylation changes associated with major psychosis.
  16. (2000). folate, methylation, and monoamine metabolism in depression.
  17. (2005). Further evidence that hyperhomocysteinemia and methylenetetrahydrofolate reductase C677T and A1289C polymorphisms are not risk factors for schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry
  18. (2010). Further evidence that methylenetetrahydrofolate reductase A1298C polymorphism is a risk factor for schizophrenia.
  19. (2004). Genetic analysis of the thermolabile methylenetetrahydrofolate reductase variant in schizophrenia and mood disorders. Psychiatr Genet
  20. (2008). Genetic associations with schizophrenia: metaanalyses of 12 candidate genes. Schizophr Res
  21. (2008). Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered
  22. (1986). Meta-analysis in clinical trials. Control Clin Trials
  23. (2009). Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data.
  24. (2008). Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls. Hum Genet
  25. (2008). Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms resulting in suboptimal oocyte maturation: a discussion of folate status, neural tube defects, schizophrenia, and vasculopathy. J Exp Clin Assist Reprod
  26. (2005). methylenetetrahydrofolate reductase 677TT genotype, and the risk for schizophrenia: a Dutch population based case-control study.
  27. (2003). Methylenetetrahydrofolate reductase gene polymorphisms in patients with schizophrenia. Brain Res Mol Brain Res
  28. (1997). Methylenetetrahydrofolate reductase variant and schizophrenia/depression.
  29. (2004). Methylomics in psychiatry: Modulation of gene-environment interactions may be through DNA methylation.
  30. (2001). Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum Mol Genet
  31. (2002). Minor physical anomalies in patients with schizophrenia.
  32. (2001). Neurodevelopmental indices and the development of psychotic symptoms in subjects at high risk of schizophrenia.
  33. (2010). No association between MTHFR C677T or A1298C and age at onset of schizophrenia.
  34. (2004). No association between polymorphisms of methylenetetrahydrofolate reductase gene and schizophrenia in both Chinese and Scottish populations. Mol Psychiatry
  35. (2005). No association found between 158 Val/Met polymorphism of the COMT gene and schizophrenia with minor physical anomalies. Psychiatry Res
  36. (2006). No association of the C677T methylenetetrahydrofolate reductase polymorphism with schizophrenia. Psychiatr Genet
  37. (2009). only susceptibility factor for schizophrenia in the Bulgarian population.
  38. (2009). Ouwehand WH; Bloodomics Consortium. Functional genomics in zebrafish permits rapid characterization of novel platelet membrane proteins. Blood
  39. (2009). Physical manifestations of neurodevelopmental disruption: are minor physical anomalies part of the syndrome of schizophrenia? Schizophr Bull
  40. (1999). Plasma homocysteine and the methylenetetrahydrofolate reductase C677T gene variant: lack of association with schizophrenia. Neuroreport
  41. (1995). Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet
  42. (2006). Serum homocysteine, folate level and methylenetetrahydrofolate reductase 677, 1298 gene polymorphism in Korean schizophrenic patients. Neuroreport
  43. (1983). The incidence of minor physical anomalies in adult male schizophrenics. Schizophr Bull
  44. (2008). Two methylenetetrahydrofolate reductase gene (MTHFR) polymorphisms, schizophrenia and bipolar disorder: an association study.